$88.21-0.11|(-0.12%)

Analyst Recommendation Trends

Wall Street analyst consensus for DNTH over the last few months:

2026-09-01
Buy: 11
S.Buy: 10
Hold: 1
Sell: 0
2026-08-01
Buy: 11
S.Buy: 10
Hold: 1
Sell: 0
2026-07-01
Buy: 11
S.Buy: 10
Hold: 1
Sell: 0
2026-06-01
Buy: 11
S.Buy: 10
Hold: 1
Sell: 0

Latest DNTH News

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on October 1, 2026, to six newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to accept

Yahoo10/1/2026

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

NEW YORK and WALTHAM, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced one oral presentation and four poster presentations for claseprubart at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting, taking place September 29 to October 2, 2026 in Orlando, Flo

Yahoo9/29/2026

Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering?

Dianthus Therapeutics (DNTH) has moved into the capital markets spotlight after filing a US$500 million follow on equity offering of common stock alongside a broad universal shelf registration. The capital raise comes after a sharp pullback in Dianthus Therapeutics' share price. The stock fell 4.99% over the last session, 8.83% across the past week and 15.11% over 30 days. However, the 90-day share price return of 2.04% and a year-to-date share price gain of 135.48% suggest that momentum has...

Yahoo9/24/2026

Dianthus Therapeutics (DNTH) Stock Looks Expensive After A 7x Run

Dianthus Therapeutics has delivered a very large 3 year return, which puts a lot of focus on whether the current share price still lines up with what its balance sheet actually supports. With the stock last closing at US$93.44, the open question is how that level stacks up against the book value backing each share. Over the past 3 years the stock has gained roughly 7x. Anyone looking at Dianthus Therapeutics now has to ask whether that kind of move is still grounded in the company’s...

Yahoo9/24/2026

This Shopify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts initiated coverage on PPG, Shopify, Chesapeake Utilities, Global Payments and Dianthus, with targets ranging from $101 to $160.

Benzinga9/11/2026

JP Morgan Initiates Coverage On Dianthus Therapeutics with Overweight Rating, Announces Price Target of $135

JP Morgan analyst Brian Cheng initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Overweight rating and announces Price Target of $135.

Benzinga9/11/2026

Dianthus: Hold, Based On Competitor C1s' CIDP Setback And Continued Claseprubart Advancement

Despite positive interim results in the CAPTIVATE trial, Dianthus faces uncertainty in CIDP, as both drugs target the same C1s pathway. See why DNTH stock is a Hold.

SeekingAlpha9/5/2026

Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen

On August 4, Dianthus Therapeutics (NASDAQ:DNTH) reported second-quarter 2026 results alongside a stack of pipeline updates that touched nearly every program the company runs. For a clinical-stage biotech with no approved product yet, the update reads less like a routine earnings drop and more like a status report on three separate autoimmune disease bets happening […]

Yahoo9/5/2026

UiPath downgraded, Shell upgraded: Wall Street's top analyst calls

UiPath downgraded, Shell upgraded: Wall Street's top analyst calls

Yahoo9/4/2026

Citigroup Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $156

Citigroup analyst Samantha Semenkow initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Buy rating and announces Price Target of $156.

Benzinga9/4/2026

Related Stocks (Peers)

Companies operating in similar sectors to DNTH:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-17CARR EDWARD-20,000--
2026-09-17CARR EDWARD-700$104.39$73,073
2026-09-17CARR EDWARD-1,100$103.2$113,520
2026-09-17CARR EDWARD-3,501$102.39$358,467
2026-09-17CARR EDWARD-6,771$101.37$686,376
2026-09-17CARR EDWARD-7,928$100.43$796,209
2026-09-17CARR EDWARD+20,000$17.88$357,600
2026-09-01Randhawa Simrat-9,375--
2026-09-01Randhawa Simrat-6,249--
2026-09-01Randhawa Simrat-7,500--
2026-09-01Randhawa Simrat-13,309$106.74$1,420,603
2026-09-01Randhawa Simrat-7,215$106.25$766,594
2026-09-01Randhawa Simrat-2,600$105.19$273,494
2026-09-01Randhawa Simrat+9,375$22.07$206,906
2026-09-01Randhawa Simrat+6,249$21.77$136,041
2026-09-01Randhawa Simrat+7,500$17.88$134,100
2026-08-19Read Simon-2,778--
2026-08-19Read Simon-2,778$117.55$326,554
2026-08-19Read Simon+2,778$18.36$51,004
2026-08-13Veness Adam M-15,000--
2026-08-13Veness Adam M+15,000$18.17$272,550
2026-08-10McGeorge Anne-6,500--
2026-08-10McGeorge Anne-1,250--
2026-08-10McGeorge Anne-700$111.41$77,987
2026-08-10McGeorge Anne-1,000$110.64$110,640
2026-08-10McGeorge Anne-1,800$109.3$196,740
2026-08-10McGeorge Anne-2,800$108.38$303,464
2026-08-10McGeorge Anne-1,450$107.58$155,991
2026-08-10McGeorge Anne+6,500$11.2$72,800
2026-08-10McGeorge Anne+1,250$19.36$24,200
2026-08-10Veness Adam M-16,167--
2026-08-10Veness Adam M-16,167$110.38$1,784,513
2026-08-10Veness Adam M+16,167$17.88$289,066
2026-08-10Read Simon-2,777--
2026-08-10Read Simon-397$111.77$44,373
2026-08-10Read Simon-470$111.05$52,194
2026-08-10Read Simon-272$109.96$29,909
2026-08-10Read Simon-831$108.95$90,537
2026-08-10Read Simon-737$108.17$79,721
2026-08-10Read Simon-70$107.11$7,498
2026-08-10Read Simon+2,777$18.36$50,986
2026-08-07Veness Adam M-3,833--
2026-08-07Veness Adam M-616$111.18$68,487
2026-08-07Veness Adam M-3,217$110.61$355,832
2026-08-07Veness Adam M+3,833$17.88$68,534
2026-08-07Garcia Marino-126,000--
2026-08-07Garcia Marino-40,000--
2026-08-07Garcia Marino-21,909$108.72$2,381,946
2026-08-07Garcia Marino-104,091$107.96$11,237,664
2026-08-07Garcia Marino-800$110.76$88,608
2026-08-07Garcia Marino-2,536$110.02$279,011
2026-08-07Garcia Marino-2,373$109.1$258,894
2026-08-07Garcia Marino-23,907$108.05$2,583,151
2026-08-07Garcia Marino-10,384$107.49$1,116,176
2026-08-07Garcia Marino+126,000$8.44$1,063,440
2026-08-07Garcia Marino+40,000$8.44$337,600
2026-07-09Savitz Ryan-31,249--
2026-07-09Savitz Ryan-5,566$101.97$567,565
2026-07-09Savitz Ryan-15,329$101.24$1,551,908
2026-07-09Savitz Ryan-10,354$100.22$1,037,678
2026-07-09Savitz Ryan+31,249$21.77$680,291
2026-06-01Randhawa Simrat-9,375--
2026-06-01Randhawa Simrat-6,249--
2026-06-01Randhawa Simrat-6,908--
2026-06-01Randhawa Simrat-3,998--
2026-06-01Randhawa Simrat-4,159$91.37$380,008
2026-06-01Randhawa Simrat-16,943$90.72$1,537,069
2026-06-01Randhawa Simrat-5,428$89.72$487,000
2026-06-01Randhawa Simrat+9,375$22.07$206,906
2026-06-01Randhawa Simrat+6,249$21.77$136,041
2026-06-01Randhawa Simrat+6,908$17.88$123,515
2026-06-01Randhawa Simrat+3,998$8.44$33,743
2026-05-21McGeorge Anne+6,090--
2026-05-21Violin Jonathan+6,090--
2026-05-21Soteropoulos Paula+6,090--
2026-05-21Read Simon+6,090--
2026-05-21Romano Steven J.+6,090--
2026-05-21Lawton Alison Frances+6,090--
2026-05-21KANGO SUJAY+6,090--
2026-05-08Soteropoulos Paula-599--
2026-05-08Soteropoulos Paula-599$85.47$51,197
2026-05-08Soteropoulos Paula+599$8.44$5,056
2026-04-09Savitz Ryan-8,224--
2026-04-09Savitz Ryan-8,224$89.84$738,844
2026-04-09Savitz Ryan+8,224$17.88$147,045
2026-03-31Savitz Ryan-40,000--
2026-03-31Savitz Ryan-74,367--
2026-03-31Savitz Ryan-7,232$85.54$618,625
2026-03-31Savitz Ryan-19,469$84.57$1,646,493
2026-03-31Savitz Ryan-59,800$83.9$5,017,220
2026-03-31Savitz Ryan-2,366$82.84$195,999
2026-03-31Savitz Ryan-800$81.36$65,088
2026-03-31Savitz Ryan-1,485$80.25$119,171
2026-03-31Savitz Ryan-21,825$78.86$1,721,120
2026-03-31Savitz Ryan-1,390$78.33$108,879
2026-03-31Savitz Ryan+40,000$17.88$715,200
2026-03-31Savitz Ryan+74,367$8.44$627,657
2026-03-31Soteropoulos Paula-599--
2026-03-31Soteropoulos Paula-599$80.11$47,986
2026-03-31Soteropoulos Paula+599$8.44$5,056
2026-03-24Soteropoulos Paula-27,594--
2026-03-24Soteropoulos Paula-27,594$78.05$2,153,712
2026-03-24Soteropoulos Paula+27,594$8.44$232,893
2026-03-16Garcia Marino-5,592--
2026-03-16Garcia Marino-59,700--
2026-03-16Garcia Marino+5,592$17.88$99,985
2026-03-16Garcia Marino+59,700$6.7$399,990
2026-03-12Randhawa Simrat-12,500--
2026-03-12Randhawa Simrat-8,332--
2026-03-12Randhawa Simrat-5,000--
2026-03-12Randhawa Simrat-7,998--
2026-03-12Randhawa Simrat-33,830$81.48$2,756,468
2026-03-12Randhawa Simrat+12,500$22.07$275,875
2026-03-12Randhawa Simrat+8,332$21.77$181,388
2026-03-12Randhawa Simrat+5,000$17.88$89,400
2026-03-12Randhawa Simrat+7,998$8.44$67,503
2026-03-12Garcia Marino-122,918--
2026-03-12Garcia Marino-900$85.53$76,977
2026-03-12Garcia Marino-200$83.38$16,676
2026-03-12Garcia Marino-12,796$82.6$1,056,950
2026-03-12Garcia Marino-65,517$81.74$5,355,360
2026-03-12Garcia Marino-43,505$80.69$3,510,418
2026-03-12Garcia Marino+122,918$6.7$823,551
2026-03-12CARR EDWARD-10,000--
2026-03-12CARR EDWARD-17,500--
2026-03-12CARR EDWARD-16,182--
2026-03-12CARR EDWARD-300$85.53$25,659
2026-03-12CARR EDWARD-200$83.38$16,676
2026-03-12CARR EDWARD-3,865$82.66$319,481
2026-03-12CARR EDWARD-23,465$81.75$1,918,264
2026-03-12CARR EDWARD-15,852$80.71$1,279,415
2026-03-12CARR EDWARD+10,000$21.77$217,700
2026-03-12CARR EDWARD+17,500$22.07$386,225
2026-03-12CARR EDWARD+16,182$17.88$289,334
2026-02-03Savitz Ryan+150,000--
2026-02-03Randhawa Simrat+150,000--
2026-02-03Veness Adam M+100,000--
2026-02-03Garcia Marino+355,000--
2026-02-03CARR EDWARD+55,000--
2025-12-04Savitz Ryan+20,000--
2025-12-04Savitz Ryan-20,000$45.18$903,600
2025-12-04Savitz Ryan+20,000$8.44$168,800
2025-11-14Randhawa Simrat-31,250--
2025-11-14Randhawa Simrat-37,494--
2025-11-14Randhawa Simrat-40,287--
2025-11-14Randhawa Simrat-109,031$38.14$4,158,442
2025-11-14Randhawa Simrat+31,250$22.07$689,688
2025-11-14Randhawa Simrat+37,494$21.77$816,244
2025-11-14Randhawa Simrat+40,287$17.88$720,332
2025-11-13Randhawa Simrat-3,529--
2025-11-13Randhawa Simrat-83,978--
2025-11-13Randhawa Simrat-18,576$37.72$700,687
2025-11-13Randhawa Simrat-42,765$37.04$1,584,016
2025-11-13Randhawa Simrat-26,166$35.8$936,743
2025-11-13Randhawa Simrat+3,529$17.88$63,099
2025-11-13Randhawa Simrat+83,978$8.44$708,774